Antifibrinolytics in the treatment of subarachnoid hemorrhage due to rupture of arterial aneurysm.
D000614:Aminocaproates / Q000009:adverse effects; D000933:Antifibrinolytic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D007611:Aprotinin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002343:Carotid Artery, Internal; D002536:Cerebral Arteries; D004359:Drug Therapy, Combination; D006801:Humans; D002532:Intracranial Aneurysm / Q000150:complications*; D002546:Ischemic Attack, Transient / Q000139:chemically induced; D012008:Recurrence; D013345:Subarachnoid Hemorrhage / Q000188:drug therapy* / Q000517:prevention & control
D000614:Aminocaproates; D000933:Antifibrinolytic Agents; D007611:Aprotinin